Standout Papers

Carbon Dot Therapeutic Platforms: Administration, Distribution, Metabolism, Excretion, Toxicity, and Therapeutic Potentia... 2022 2026 2023 2024158
  1. Carbon Dot Therapeutic Platforms: Administration, Distribution, Metabolism, Excretion, Toxicity, and Therapeutic Potential (2022)
    Adam Truskewycz, Hong Yin et al. Small

Immediate Impact

36 standout
Sub-graph 1 of 16

Citing Papers

AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Breast cancer: pathogenesis and treatments
2025 Standout
3 intermediate papers

Works of Agata Rybicka being referenced

Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
2018
Abstract B027: BGB324, a selective small molecule inhibitor of AXL receptor tyrosine kinase, enhances immune checkpoint inhibitor efficacy
2016

Author Peers

Author Last Decade Papers Cites
Agata Rybicka 72 89 31 132 10 302
Thilo Papp 150 162 32 40 15 354
Guizhu Yang 148 193 72 43 12 364
Carolyn Van Pelt 175 169 20 28 12 357
Sarah May 52 90 79 69 9 331
Julien Daubriac 54 91 31 75 12 342
Maria Rita Fabbrizi 56 115 23 96 17 288
Wei Xia 44 208 20 37 15 329
Ali Vedadi 55 81 31 61 8 282
Chiara Mauriello Jimenez 34 68 11 114 9 281
Zhaohua Xia 35 87 28 46 17 269

All Works

Loading papers...

Rankless by CCL
2026